Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Morimoto

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Arthritis Research & Therapy|March 24, 2011
Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cellsToshio Kawamoto, Yoshiyuki Abe, Jun Ito, et al.
Inflammation and Regeneration|January 12, 2018
Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositisTakuya Hirai, Keigo Ikeda, Hiroshi Tsushima, et al.
Annals of Dermatology|February 2, 2018
Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and PatientsKunihiro Hayakawa, Keigo Ikeda, Maki Fujishiro, et al.
Autoimmunity|November 21, 2015
Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritisTomoko Miyashita, Shinji Morimoto, Maki Fujishiro, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2017
Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination TherapiesKeigo Ikeda, Kozo Watanabe, Takuya Hirai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
Rapid shift in methane carbon isotopes suggests microbial emissions drove record high atmospheric methane growth in 2020-2022Sylvia Englund Michel, Xin Lan, John Miller, et al.
Modern Rheumatology|June 20, 2008
Decrease in CD4+CD25+ and CD8+CD28+ T cells in interstitial pneumonitis associated with rheumatic diseaseAkira Katagiri, Shinji Morimoto, Yutaka Nakiri, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2025
miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritisHiroyuki Tomita, Kunihiro Hayakawa, Keigo Ikeda, et al.
Biomed Research International|September 24, 2013
Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with tocilizumab: an anti-interleukin-6 receptor antibodyMitsuaki Yanagida, Mikiko Kawasaki, Maki Fujishiro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 15, 2015
Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal studyNaoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Arthritis Research & Therapy|March 24, 2011
Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cellsToshio Kawamoto, Yoshiyuki Abe, Jun Ito, et al.
Inflammation and Regeneration|January 12, 2018
Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositisTakuya Hirai, Keigo Ikeda, Hiroshi Tsushima, et al.
Annals of Dermatology|February 2, 2018
Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and PatientsKunihiro Hayakawa, Keigo Ikeda, Maki Fujishiro, et al.
Autoimmunity|November 21, 2015
Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritisTomoko Miyashita, Shinji Morimoto, Maki Fujishiro, et al.
Internal Medicine (Tokyo, Japan)|May 16, 2017
Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination TherapiesKeigo Ikeda, Kozo Watanabe, Takuya Hirai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
Rapid shift in methane carbon isotopes suggests microbial emissions drove record high atmospheric methane growth in 2020-2022Sylvia Englund Michel, Xin Lan, John Miller, et al.
Modern Rheumatology|June 20, 2008
Decrease in CD4+CD25+ and CD8+CD28+ T cells in interstitial pneumonitis associated with rheumatic diseaseAkira Katagiri, Shinji Morimoto, Yutaka Nakiri, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2025
miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritisHiroyuki Tomita, Kunihiro Hayakawa, Keigo Ikeda, et al.
Biomed Research International|September 24, 2013
Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with tocilizumab: an anti-interleukin-6 receptor antibodyMitsuaki Yanagida, Mikiko Kawasaki, Maki Fujishiro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 15, 2015
Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal studyNaoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, et al.
Pageof 11